Alexandria Real Estate Equities (NYSE:ARE) Secures Largest Life Science Lease in History

Alexandria Real Estate Equities (NYSE:ARE) recently secured a significant 16-year lease for a massive research hub in their San Diego megacampus, marking the largest life science lease in the company's history. This event underscores strong demand within the life science real estate sector, potentially supporting the company's 10% share price increase over the past month. During this time, while major indexes remained near all-time highs despite trade uncertainties, Alexandria's expansion move may have positively influenced investor sentiment, adding weight to the broader uptrend observed in the market.

We've identified 3 weaknesses with Alexandria Real Estate Equities (at least 1 which shouldn't be ignored) and understanding the impact should be part of your investment process.

NYSE:ARE Earnings Per Share Growth as at Jul 2025
NYSE:ARE Earnings Per Share Growth as at Jul 2025

Find companies with promising cash flow potential yet trading below their fair value.

The recent long-term lease secured by Alexandria Real Estate Equities for a research hub in their San Diego megacampus could bolster the company's revenue and occupancy stability, as highlighted in the narrative. This expansion caters to the sustained demand in the life science sector, potentially enhancing revenue projections. While the recent 10% increase in Alexandria's share price over the past month reflects positive sentiment, its 12-month total return of 33.76% illustrates broader challenges impacting its performance.

Over the past year, Alexandria's shares underperformed the US Health Care REITs industry, which posted a 19.7% return, and the broader US market's 11.4% gain. This underperformance factors into the valuation context, with the company's shares trading at a 33.5% discount to the consensus price target of US$107.69. With forecasted revenues of $3.11 billion translating into expected earnings of $406.2 million by May 2028, the market remains cautious. Current forecasts suggest a potential uplift in earnings, yet these remain contingent on successful execution amidst macroeconomic and regulatory pressures. The ongoing expansion could contribute positively to the company's long-term growth strategy, supporting both revenue and earnings growth expectations.

Our comprehensive valuation report raises the possibility that Alexandria Real Estate Equities is priced higher than what may be justified by its financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:ARE

Alexandria Real Estate Equities

An S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.

Undervalued established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.7% undervalued
12 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.9% undervalued
33 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38027.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative

Updated Narratives

SL
NXT logo
Slv on Nueva Expresión Textil ·

Nueva Expresion Textil SA (BME:NXTE) – The Hidden "Green Gem" In CAFTA and Portugal. Small-Cap Textiles.

Fair Value:€1.743.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
NGEX logo
RockeTeller on NGEx Minerals ·

Lundin-Backed: 10x High-Grade Copper-Gold Discovery + Billion-Pound Resource Anchor

Fair Value:CA$4128.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0535.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9721.8% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1932.0% undervalued
47 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative